Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment (Q48669202)

14 February 2018

title

Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment (English)

1 reference

14 February 2018

1 reference

14 February 2018

Dejan Milatovic

object named as

Dejan Milatovic

1 reference

14 February 2018

Thomas J Montine

object named as

Thomas J Montine

1 reference

14 February 2018

Kathleen S. Montine

object named as

Kathleen S Montine

1 reference

14 February 2018

author name string

Jason D Morrow

1 reference

14 February 2018

Balz Frei

1 reference

14 February 2018

Felix Eckenstein

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

14 February 2018

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

14 February 2018

volume

930

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

75-82

1 reference

14 February 2018

Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

The free radical theory of aging matures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1 and interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Oxidants, oxidative stress and the biology of ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Brain eicosanoids and LPS fever: species and age differences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Does oxidative damage to DNA increase with age?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Cyclooxygenases and the Central Nervous System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

N‐methyl‐D‐aspartate‐evoked release of cyclo‐oxygenase products in rabbit hippocampus: An in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic alzheimer neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Anti-inflammatory drugs and Alzheimer-type pathology in aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Increased CSF F2-isoprostane concentration in probable AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Elevated CSF prostaglandin E2 levels in patients with probable AD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Decreased Expression of Prostaglandin G/H Synthase-2 (PGHS-2) in Alzheimer’s Disease Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Clinical trial of indomethacin in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Improved quantification of 8-epi-prostaglandin F2α and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2α in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Cyclooxygenases: structural, cellular, and molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903409-6

10.1016/S0006-8993(01)03409-6

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018